Augmentation of hormonal activities with antibodies from cattle immunized with a combination of synthetic and recombinant growth hormone peptide.
Antibodies generated against a synthetic growth hormone (GH) peptide in a number of animal species were shown to enhance the efficacy of GH. However, the ability to produce the effective antibodies diminished over the time and repeated boosters failed to overcome the hurdle. Therefore, this study was designed to address the issue on the fallen antibody responses by employing different GH peptide antigen preparations in cattle. Holstein steers were repeatedly immunized with a synthetic peptide corresponding to an amino acid sequence 54-95 of porcine GH (pGH). The peptide was conjugated to ovalbumin (OVA) as a carrier. Animals initially responded to the antigen well and elicited antibodies specific to the peptide. However, the 4th challenge with the same OVA-peptide antigen rendered animals unresponsive, resulting in a decline in antibody production. This unresponsiveness was overcome by switching the antigen at the 5th immunization from OVA-peptide to a recombinant peptide preparation which was composed of maltose binding protein (MBP) as a carrier. Antibodies generated in cattle after the 5th immunization recognized not only the pGH(54-95) peptide, but also bovine GH (bGH) and pGH. These antibodies were not immunoreactive with an unrelated control peptide. Hypophysectomized (hypox) rats were used for functional analysis and bGH was active in promoting the growth of these GH-deficient rats. The growth-promoting effect of bGH was significantly enhanced by mixing with bovine anti-peptide antibodies prior to administration. Therefore, the present findings suggest that peptide 54-95 induces cattle to elicit antibodies capable of not only recognizing bGH but also augmenting the somatogenic effectiveness of bGH in hypox rats.
Wang
B S
BS
Laboratory of Immunoendocrinology, Fort Dodge Animal Health, Cyanamid Agricultural Research Center, Princeton, New Jersey 08543-0400, USA.
Search
D J
DJ
Lumanglas
A A
AA
Ingling
J
J
Corbett
M J
MJ
Shieh
H M
HM
Kraft
L A
LA
D000818:Animals; D000906:Antibodies; D000917:Antibody Formation / Q000502:physiology; D000918:Antibody Specificity; D002417:Cattle / Q000276:immunology / Q000378:metabolism*; D005260:Female; D013006:Growth Hormone / Q000276:immunology* / Q000494:pharmacology*; D008297:Male; D010047:Ovalbumin; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000276:immunology; D010865:Pilot Projects; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000276:immunology / Q000494:pharmacology; D014614:Vaccines, Synthetic
D000906:Antibodies; D010446:Peptide Fragments; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; D013006:Growth Hormone; D010047:Ovalbumin